International Precision Medicine Conference
March 13-15, 2025
Drug target discovery and integration with individualized therapy
Drug target discovery and integration with individualized therapy
A good drug target is one that is relevant to the disease phenotype and may be modulated therapeutically. The identification and early validation of disease-modifying targets, known as target discovery, is an important first stage in the drug discovery process. Indeed, the completion of the human genome project has fueled interest in determining protein function in both academia and industry. Individualized pharmaceutical therapy tries to produce predictable and optimal therapeutic responses in specific patients. To do so, production platforms and technology that can personalize products to individual patient needs are required.
- Drug discovery pipeline
- 3-D printing
- Patient-centric drug product
- Mass customization
- Design requirements
Committee Members
Roy Gary Beran
University of New South Wales, Australia
Ewa Danuta Bialek
Institute of Psychosynthesis, Poland
Sergey Suchkov
The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation IPMC 2022 Speakers
Jinyuan Zhou
Johns Hopkins University School of Medicine, United States
Wei Wu
UCSF, United States
Xu Chen
The College of St. Scholastica, United States
Styliani Geronikolou
University Research Institute of Maternal and Child health & Precision Medicine, Greece
Title : Precision Pharmacotherapy in the Treatment of Epilepsy - Use of Antiseizure Medications and Therapeutic Blood Level Monitoring
Roy Gary Beran, University of New South Wales, Australia
Title : When something comes on time, it is education, if too late, it is therapy. Health or disease - It is our choice
Ewa Danuta Bialek, Institute of Psychosynthesis, Poland
Title : Antibody-Proteases as translational tools of the newest generation to be applied for biodesign and bioengineering to get Precision and Personalized healthcare services Re-armed
Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Title : Exposome for precision medicine
Styliani Geronikolou, University Research Institute of Maternal and Child health & Precision Medicine, Greece
Title : Precision Diagnostics and Medical Devices: Innovative Imaging Technologies for Lung Cancer Screening in Large Populations
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Use of indocyanine green fluorescence imaging in the extrahepatic biliary tract surgery
Orestis Ioannidis, Aristotle University of Thessaloniki, Greece